OMID Holdings, Inc. (OMID) Stock Analysis

OMID Holdings, Inc. (OMID) Healthcare & Pipeline Overview

OMID Holdings, Inc. is a health and wellness company engaged in the manufacturing and distribution of CBD-based products. Operating within the specialty and generic drug manufacturing sector, OMID aims to capitalize on the growing market for CBD wellness solutions, though it faces competition from established players.

What Is the Investment Thesis for OMID?

Investing in OMID Holdings, Inc. presents a speculative opportunity within the burgeoning CBD market. The company's focus on manufacturing and selling CBD-based products aligns with the increasing consumer interest in alternative wellness solutions. However, the absence of detailed financial data and AI analysis makes it difficult to assess the company's true potential. Key value drivers include OMID's ability to innovate and differentiate its product offerings, expand its distribution network, and effectively market its brand. Growth catalysts include the potential for regulatory changes that could broaden the market for CBD products and increased consumer awareness of the potential health benefits of CBD. Potential risks include intense competition from established players, evolving regulatory landscape, and the need to secure adequate funding for growth. Given the limited information available, a thorough due diligence process is essential before considering an investment in OMID Holdings, Inc.

Based on FMP financials and quantitative analysis

OMID Key Highlights

OMID Holdings, Inc. operates in the health and wellness sector, focusing on CBD-based products.

• The company is based in Phillipsburg, New Jersey.
• OMID's market capitalization is $0.00B, indicating it is a micro-cap company.
• The company's beta is 1.00, suggesting its stock price is as volatile as the market average.
• OMID does not currently offer a dividend.

Who Are OMID's Competitors?

OMID is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are OMID's Key Strengths?

Focus on the growing CBD market.

• Potential for product innovation.
• Direct-to-consumer sales channel (if established).

What Are OMID's Weaknesses?

Limited brand recognition.

• Small market capitalization.
• Dependence on a single product category (CBD).

What Could Drive OMID Stock Higher?

Potential changes in regulations regarding CBD products.

• Increasing consumer awareness of the potential health benefits of CBD.
• Expansion of distribution network through strategic partnerships.

What Are the Key Risks for OMID?

Financial-distress signal — its Altman Z-Score of -2.66 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-70.1%) — the business is not currently generating profit on shareholder capital.
• Intense competition from established players in the health and wellness industry.
• Evolving regulatory landscape surrounding CBD products.
• Negative publicity or consumer perception regarding CBD products.
• Dependence on a single product category (CBD).
• Need to secure adequate funding for growth and expansion.

What Are the Growth Opportunities for OMID?

• Expansion of Product Line: OMID Holdings, Inc. has the opportunity to expand its product line to include a wider range of CBD-based products, such as edibles, topicals, and beverages. The market for CBD-infused products is rapidly growing, with a projected market size of $16 billion by 2026. By diversifying its product offerings, OMID can attract a broader customer base and increase its revenue potential. The timeline for this growth opportunity is immediate, as the company can begin developing and launching new products within the next year. The competitive advantage lies in OMID's ability to formulate unique and effective CBD products that meet the specific needs of consumers.
• Strategic Partnerships: OMID Holdings, Inc. can pursue strategic partnerships with established retailers and distributors to expand its market reach. The retail market for CBD products is highly fragmented, with numerous independent stores and online retailers. By partnering with larger retailers, OMID can gain access to a wider customer base and increase its brand visibility. The timeline for this growth opportunity is medium-term, as it may take time to negotiate and establish partnerships with key retailers. The competitive advantage lies in OMID's ability to offer retailers high-quality CBD products at competitive prices.
• E-commerce Expansion: OMID Holdings, Inc. can invest in its e-commerce platform to increase online sales. The online market for CBD products is growing rapidly, with consumers increasingly preferring to purchase CBD products online. By improving its website, enhancing its online marketing efforts, and offering convenient shipping options, OMID can attract more online customers and increase its revenue. The timeline for this growth opportunity is short-term, as the company can implement improvements to its e-commerce platform within the next few months. The competitive advantage lies in OMID's ability to create a user-friendly and informative online shopping experience.
• Geographic Expansion: OMID Holdings, Inc. can expand its operations to new geographic markets, both domestically and internationally. The market for CBD products is growing globally, with increasing demand in Europe, Asia, and Latin America. By expanding its geographic reach, OMID can tap into new customer bases and increase its revenue potential. The timeline for this growth opportunity is long-term, as it may take time to navigate regulatory requirements and establish distribution networks in new markets. The competitive advantage lies in OMID's ability to adapt its products and marketing strategies to the specific needs of different geographic markets.
• Research and Development: OMID Holdings, Inc. can invest in research and development to develop new and innovative CBD products. The market for CBD products is constantly evolving, with new research emerging on the potential health benefits of CBD. By investing in research and development, OMID can stay ahead of the curve and develop products that meet the changing needs of consumers. The timeline for this growth opportunity is long-term, as it may take time to conduct research and develop new products. The competitive advantage lies in OMID's ability to create scientifically-backed CBD products that are more effective and safer than competing products.

What Are OMID's Competitive Advantages?

• Brand recognition (if established).
• Proprietary formulations (if any).
• Distribution network (if extensive).

What Does OMID Do?

OMID Holdings, Inc. is a health and wellness company that focuses on the manufacturing and sale of CBD-based products. Based in Phillipsburg, New Jersey, the company aims to provide consumers with access to a range of health and wellness solutions derived from cannabidiol (CBD). While the company's founding story and evolution are not detailed in the provided data, its current market position centers on leveraging the growing demand for CBD products. OMID's product offerings likely encompass various CBD formats, such as oils, tinctures, edibles, topicals, and capsules, targeting different consumer preferences and needs. The company's geographic reach is currently unspecified, but it can be inferred that OMID initially focuses on the United States market, given its headquarters location. OMID's competitive positioning within the specialty and generic drug manufacturing industry involves differentiating itself through product innovation, quality control, and effective marketing strategies. As a smaller player in a competitive landscape, OMID faces challenges from larger, more established companies with greater resources and brand recognition. The company's success depends on its ability to establish a strong brand presence, build customer loyalty, and navigate the evolving regulatory environment surrounding CBD products.

What Products and Services Does OMID Offer?

• Manufactures CBD-based products.
• Sells CBD-based products directly to consumers.
• Potentially distributes CBD products through retail partners.
• Focuses on health and wellness solutions.
• Operates in the specialty and generic drug manufacturing industry.
• Aims to capitalize on the growing market for CBD wellness solutions.

How Does OMID Make Money?

• OMID Holdings, Inc. generates revenue through the sale of CBD-based products.
• The company may utilize both direct-to-consumer sales channels and retail partnerships.
• Profitability depends on efficient manufacturing, effective marketing, and competitive pricing.

What Industry Does OMID Operate In?

OMID Holdings, Inc. operates within the Drug Manufacturers - Specialty & Generic industry, a segment of the broader healthcare sector. The industry is characterized by intense competition, evolving regulatory landscapes, and increasing consumer demand for specialized and generic medications. The market for CBD-based products has experienced significant growth in recent years, driven by increasing consumer awareness of potential health benefits and the relaxation of regulations in some jurisdictions. However, the industry remains fragmented, with numerous players vying for market share. OMID's success depends on its ability to differentiate itself through product innovation, quality control, and effective marketing strategies. The company faces competition from established pharmaceutical companies, as well as smaller, specialized CBD manufacturers.

Who Are OMID's Key Customers?

• Individuals seeking health and wellness solutions.
• Consumers interested in alternative therapies.
• Retailers and distributors of health and wellness products.

How OMID Holdings, Inc. Is Valued

OMID Holdings, Inc. carries a market capitalization of $2.12M, placing it in the micro-cap category.

Company Profile

OMID Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Phillipsburg, US. The company is led by CEO Adam Frank. OMID has traded publicly since 2013.

Return on equity for OMID Holdings, Inc. stands at -70.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -42.5%, showing how much profit it generates from its asset base. Its free cash flow yield is -4.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 28.80 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -5.3%, the inverse of the P/E and a quick read on earnings relative to price.

OMID Holdings, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.66 places it in the distress zone, a signal of elevated financial risk.

OMID Financials

OMID Latest News

No recent news available for OMID.

OMID Analyst Consensus

OMID MoonshotScore

OMID Holdings, Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources